- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Patent holdings for IPC class C07K 16/28
Total number of patents in this class: 49466
10-year publication summary
|
2114
|
2480
|
2884
|
3456
|
3730
|
4048
|
4191
|
4142
|
4644
|
3962
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4417 |
1018 |
| Genentech, Inc. | 4006 |
782 |
| Hoffmann-La Roche Inc. | 3523 |
600 |
| F. Hoffmann-La Roche AG | 7931 |
591 |
| Immatics Biotechnologies GmbH | 1157 |
577 |
| The Regents of the University of California | 20245 |
575 |
| Amgen Inc. | 4161 |
570 |
| Bristol-myers Squibb Company | 4833 |
562 |
| Novartis AG | 10635 |
560 |
| Janssen Biotech, Inc. | 1576 |
454 |
| Memorial Sloan-Kettering Cancer Center | 1975 |
432 |
| Chugai Seiyaku Kabushiki Kaisha | 1375 |
391 |
| The Trustees of the University of Pennsylvania | 4377 |
345 |
| The Board of Trustees of the Leland Stanford Junior University | 6522 |
323 |
| Board of Regents, The University of Texas System | 5921 |
309 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3370 |
307 |
| Genmab A/S | 439 |
293 |
| Xencor, Inc. | 390 |
280 |
| Dana-Farber Cancer Institute, Inc. | 2620 |
265 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2897 |
261 |
| Other owners | 39971 |